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ABSTRACI' NuIrerous recipients of liver transplants have 
had chronic survival, but further improvenent will 
necessitate new and better techniques of inmmosuppres-
sion. 
INI'ROOUCl'ION 
There are two kinds of liver transplantation. One in-
volves the pl.acement of an extra (auxiliary) liver at sare 
heterotopic site such as the right paravertebral gutter, 
leaving the diseased native liver in place. 0ptim:mI revascu-
larization of auxiliary livers includes portal inflow fran the 
splanchnic venous system. There has been only one example of 
long survival after clinical auxiliary transplantation, that 
being of a patient treated for biliary atresia nore than six 
years ago by Fortner of New York. Forty-two other attarpts 
throughout the world including four fran our center failed 
within a short title (1). 
The second and far nore widely accepted kind of liver 
transplantation is liver replacement ( orthotopic liver trans-
plantation) after rE!lOVal of the diseased native organ. The 
following remarks will pertain solely to orthotopic liver 
transplantation. 
Indications For Transplantation 
Arrongst the first 141 recipients treated by us (2, 3) 
, there were 74 infants and children (Table 1). The IlOst cormon 
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diagnosis in this pediatric group was biliary atresia. Chronic 
aggressive hepatitis was a distant second. Eight patients had 
the inborn errors of rretaJ::olism sunmarized in Table 1. It has 
been established that liver based inborn errors are permanently 
rectified by providing livers of nomal phenotypes. 
TABLE 1 
INDICATIONS FOR TRANSPIANTATION (1963-1977) 
IN PATIENTS-18 YEARS 
BILIARY ATRESIA 48 
CHRONIC AGGRESSIVE HEPATITIS 12 
INOORN MRrAOOLIC ERRORS 8* 
HEPA'lG1A 3 
NIDNA'12Uo HEPATITIS 2 
CONGENI'12Uo BILIARY CIRRHOSIS 1 
'IDI'AL 74 
*INOORN ERRORS 
ALPHA, -ANTITRYPSIN DEFICIENCY 
WII.SON'S DISEASE 
TYROSINEMIA 





There were 67 adults arrong the first 141 liver recipients. 
'!he reasons for proceeding are listed in Table 2. These indi-
cations are all still considered valid with the exception of 
primary hepatic malignancies. Excluding hepatic malignancies, 
the rrost camon indications for operation were chronic aggres-
sive hepatitis and alcoholic cirrhosis. 
TABLE 2 
INDICATIONS FOR TRANSPIANl'ATION (1963-1977) 
IN PATIENTS 19 'ID 70 YEARS OLD 
CHRONIC AGGRESSIVE HEPATITIS 23 
PRIMARY LIVER MALIGNAN.:Y 16 
AICOHOLIC CIRRHOSIS 15 
PRIMARY BILIARY CIRRHOSIS 5 
SCLEROSING CHOIANGITIS 4 
SEX::QNDl.\RY BILIARY CIRRHOSIS 2 
MASSIVE HEPATIC NOCROSIS (B VIRUS) 1 
BUDD-CHIARI SYNDRCME 1 
'IDI'AL 67 
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Three of our liver transplantations in children and 16 in 
adults were carried out to treat nonresectable hepatonas, duct 
cell carcinorras, angiosarcorras, and cholangiocarcinarra. Ten 
of these patients lived beyond three rronths and nine of them 
later developed metastases which usually contributed to or 
were prirrarily responsible for their deaths after a few rronths 
to several years. Similarly, the recurrence rate in the cam-
bridge-King's College series in England has been 70% (4). As 
rrore and rrore such cases have been docurrented, we have had less 
and less enthusiasm for and indeed we usually avoid transplan-
tation for malignancy. 
In the future, the leading indications for transplantation 
in adults undoubtedly will be chronic aggressive hepatitis and 
Laennec's cirrhosis. The presence of IIBs Ag viremia is not a 
contraindication since effective postoperative treatment can be 
given with hyperimmune serum (4). cases of cirrhosis pose a 
suprerre technical challenge. If results are to be ircproved, 
candidates will need to be selected at an earlier tirre. Too 
often in the past, the recipients have been rroribund by the 
tirre of operations. 
Relative contraindications include advanced age (beyond 
50 years) and infection. Judgment ITU.lSt be exercised not to 
proceed too soon in the natural history of the patient's dis-
ease, and not to rrake the equally or rrore serious error of 
waiting too long. 
Operative Procedure 
Liver replacement is simple in principle. However, its 
performance nay be one of the rrost difficult undertakings in 
surgery. Blood loss nay total thousands of milliliters. In 
cirrhotics, the combination of venous hypertension and defic-
ient clotting factors may rrake hemostasis completely impossible 
until the arrival of a new liver. Then, the synthesis of 
clotting factors by the homograft, combined with portal venous 
decompression through the transplant, can lead to a nearly 
miraculous cessation of hemorrhage. 
Since 1968, practically all liver homografts used in 
Denver have been rerroved fram heartbeating cadaveric donors. 
Even with this advantage, organs that have been irreparably 
damaged are still occasionally used. Unfortunately, there are 
no present methods to rule out this kind of pre-existing 
ischemic injury. 
Horrograft preservation is started by infusing cold elec-
trolyte solution just as the donor blood supply is interrupted. 
Our usual practice is to infuse only the portal vein. With 
the so-called Collins solution which was first used to store 
kidneys, preservation of cold livers has been possible in dogs 
for as long as one day. Similar results have been reported by 
--------------- ... _- .. --_._._--_. 
548 THOMAS E. STARZL 
CaIne et al using a modified plasma solution (4). These de-
velopments in preservation have permitted the successful ship-
rrent of livers from city to city in the United States, and also 
in the English program of Calne and Williams (4). 
The first anastorrosis perforrred is of the suprahepatic 
vena cava. As the vena caval anastorroses are constructed, slow 
infusion of electrolyte solution is continued via the portal 
vein. Air bubbles can be seen floating out of the graft. If 
infusion is not provided during this tirre, the air bubbles in 
the homograft may be flushed into the circulation after revas-
cularization. Then, they may pass through abnormal right to 
left venous carmunications (secondary to liver disease) and on 
to the brain. A high incidence of cerebral air embolus was 
encountered in our early experience. This was eliminated with 
the infusion technique. 
The hilar structures have smaller calibers. Increasingly 
in infants and young recipients, we have used microvascular 
techniques, particularly for reconstruction of the hepatic 
artery and portal vein. Otherwise, pediatric recipients will 
have a high incidence of thrombosis in these vessels. 
Biliary tract reconstruction has caused more complications 
than any other part of the operation (3). In our early exper-
ience, one of every three recipients subsequently had biliary 
duct obstruction or biliary fistula. Even without obstruction 
or fistula, there was a high incidence of bacteremia, probably 
because of constant contamination of the biliary ducts through 
the cholecystoduodenostames that were being used in those 
early days. 
Now we think that duct to duct reconstruction (chole-
dochocholedochostomy) is the best rrethod. If this is not 
feasible (as for example in patients with biliary atresia), we 




The procedure has been followed by a long list of corrpli-
cations. Such complications have been responsible for more 
than half of all deaths within the first year (2,3,5). Inclu-
ded have been vascular thromboses, herrorrhage, the unknowing 
use of ischemically damaged grafts, and biliary tract obstruc-
tion and/or fistulization to provide a very incomplete account-
ing. These complications have influenced postoperative inmuno-
suppressive management. 
It is now realized that biliary tract complications (es-
pecially obstruction) frequently have been the cause of post-
operative jaundice that developed after an initial period of 
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bilirubin clearing. Better diagnosis and managerrent of 
biliary complications were made feasible by increasing the 
use of cholangiography (percutaneous, retrograde endoscopic, 
or T-tube). 
Another recent change in policy has been the rrore fre-
quent use of needle biopsy. Evidence of virus hepatitis 
has thereby been obtained in a suprising number of cases. 
Severe or lethal horrograft hepatitis has been caused by 
HBs Ag virus, herpes, chicken pox, and adenovirus. 
Immunosuppression 
All of our liver recipients have had double drug therapy 
using a cytotoxic agent, azathioprine (which can be used 
interchangeably with cyclophosphamide), and prednisone. 'Ib 
the double drug regirren we have often added heterologous anti-
lyrrphocyte globulin (ALG). Irreversible hepatic rejection 
has usually been prevented with these tedmiques but too 
often at the cost of fatal infection. The possibilities for 
rrore effective llrmunosuppression are discussed belCM, and it 
is upon such advances that the next major jmnp in survival 
will undoubtedly depend. 
Survival 
In reporting our experience (2,3,5), ~ have divided 
our cases of orthotopic liver transplantation into three 
series. Series 1 consisted of 111 consecutive patients 
treated between March, 1963 and July, 1976. Of these, only 
31 (28%) survived for as long as one year (Table 3). The 
rate of chronic survival improved only slightly during this 
tine. 
TABIE 3 
CASES OF LIVER REPlACEMENT AT THE UNIVERSITY OF COIDRAOO 
(FOI..LCM-UP 'lD JANUARY 1, 1980) 
TOl'AL LIVED 1 YE'AR* ALIVE N::M 
(YEARS) 
SERIES I 
(3/63-7/76) III 31 (28%) 13 (4-10) 
SERIES II 
(7/76-1/78) 30 15 (50%) 13 (2-3 1/2) 
SERIES III 
(3/78-1/79) 23 6 (26%) 5 (1-1 3/4) 
*Iate deaths after Ito 6 years. 
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Subsequent to one year (12 to 72 nonths postoperative) , 
18 nore deaths occurred in Series 1 leaving today only 13 
alive after 4 to 10 years. The rrost com:ron cause of death 
after one year was chronic rejection, although recurrent 
neoplasm, unrecognized biliary tract obstructions, and 
hepatitis all contributed. 
In July, 1976, a Series 2 was begun. It was canpleted 
in Decerriber, 1977. The operative, diagnostic, and rranagement 
improvements alluded to earlier were used. Of the next 30 
consecutive recipients, 13 are alive after 2 to 3 1/2 years 
(Table 3). A fourteenth recipient, a child, died at 23 
nonths of systemic chicken pox and bacterial infection. A 
fifteenth patient died after 16.5 nonths with chronic re-
jection and portal vein thrombosis. Thus, the one-year 
survival in this experience was 50% (Table 3). 
It is disquieting to report that these improved results 
have not been sustained at our center in a subsequent, smaller 
experience of 23 nore consecutive cases for which a min.imum 
potential follow-up of one year is no.v available (Table 3). 
Of the 23 recipients, only 6 (26%) lived for a full year. 
As in earlier t.irres, faulty case selection, technical c0m-
plications, use of danaged organs, and complications of 
inmunosuppression were the ma.in causes of death. By per-
sonal conmunication it was learned that a recent decline in 
survival was also noted by the English team in 1978 and 
early 1979. 
DISCUSSION 
VE have shown in renal transplant recipients that pre-
operative lymphoid depletion by thoracic duct drainage can 
practically eliminate rejection. Such an improvement in 
immunosuppression should be applicable for other organs, 
but there ma.y be special problems in liver recipients. 
Prospective liver recipients are so fragile that a nonth of 
TDD pretreat.rrent ma.y impose significant risks. For one 
thing, the lymph drainage in patients with hepatic disease 
tends to be voluminous, particularly if ascites is present. 
In our experience, the output ma.y exceed one liter per hour. 
Nevertheless, as our liver program reopens, we are atterrpt-
ing to provide pretreatment with TDD or alternatively by 
renoving peripheral lymphocytes (lymphapheresis). 
Another possibility for irrprovement could be better 
drug treat.rrent. A prauising new agent, the fungus extract, 
Cyclosporin A has permitted spectacular success after skin 
and/or whole organ transplantation in rats, rabbits, dogs 
and pigs and has been used by calne in a limited clinical 
trial of renal hOIIDtransplantation at Cambridge, England. 
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Calne says that several human recipients of cadaver kidneys 
have been treated with this drug and discharged from the 
hospital in good condition even though no corticosteroids 
were given. It has been stated that Cyclosporin has sig-
nificant hepatotoxicity. 'Ib the extent that this is true, 
its value will be diminished. 
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At the University of Colorado the first American trials 
of Cyclosporin A in kidney transplants are underway. So 
far, 15 cases have been COIllpiled. No irreversible rejec-
tions have been encountered although one kidney was lost 
because of ureteral necrosis. No examples of severe 
hepatotoxicity have been seen. Thus, the stage has been 
set for a trial of Cyclosporin A in liver transplantation. 
Perusal of the references below will provide a nearly 
complete picture of the history and present state of liver 
transplantation. Scholars interested in original publica-
tions will be able to track these easily, especially in 
Reference 2. 
1. Fortner, J.G., Yeh, S.D.J., Kim, D.K., Shiu, M.H. and 
Kinne, D.W. (1979). The case for technique of hetero-
topic liver grafting. Transplantation Proc. 11, 269. 
This collection of 43 clinical auxiliary liver 
transplantations from many different centers was pre-
sented to the International Transplantation Society in 
Raile, September, 1978. The case for auxiliary trans-
plantation is presented optimistically, perhaps ex-
cessively so in view of the poor results. 
2. Starzl, T.E. (with the assistance of Putnam, C.W.) 
(1969). "Experience in Hepatic Transplantation." 
W. B. Saunders, Philadelphia. 
This text contains the total world literature 
(299 references) on experimental and clinical liver 
transplantation to the spring of 1969. An account is 
given of all 42 human liver harotransplantations 
attempted to that time including 29 (25 orthotopic, 
4 auxiliary) at the University of Colorado. Surgical 
and anesthetic techniques, and rreta}:x)lic and inmuno-
globulin changes following liver transplantation are 
described. The laboratory developrrent and clinical 
practice of immunosuppression for all transplanted 
organs is reviewed. Two chapters by Professor K.A. Porter 
of St. Mary's Hospital and Medical School, London, 
constitute a complete monograph of the pathology of 
aninal and human auxiliary and orthotopic liver horro-
grafts as well as two chimpanzee to human heterografts. 
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3. Starzl, T.E., Koep, L.J., Halgrimson, C.G., Hood, J., 
Schroter, G.P.J., Porter, K.A. and weil, R., III (1979). 
Fifteen years of clinical liver transplantation. 
Gastroenterology 77, 375. 
The first 141 orthotopic liver horrotransplantations 
at the University of Colorado are described. These in-
clude the 74 pediatric cases of this chapter plus 67 
adult cases. There is a detailed d.ocurrentation of 
causes of early and especially late deaths. The recent 
literature of clinical liver transplantation is brought 
up-to-date. This is the rrost recently written review 
of liver transplantation. 
4. Caine, R. Y. and Williams, R. (1979). Liver transplanta-
tion. "Current Problems in Surgery 16, 3-44. {Ravitch, 
M.M., Ed.)." Yearbook Medical Publishers, Inc., Chicago. 
The iJrp::)rtant clinical series of 74 cases from the 
cambridge-King's College London group are described, 
as well as laboratory research in these institutions. 
Although alrrost all of the recipients were adults, the 
opinions expressed have applicability to pediatric 
cases. Opinions about patient selection, biliary tract 
reconstruction and immunosuppression are sorrewhat dif-
ferent that those held by us. 
5. Starzl, T.E., Koep, L., Porter, K.A., Schroter, G.P.J., 
Weil, R., III, Hartley, R.B. and Halgrimson, C.G. 
(IN PRESS). Decline in survival after liver transplanta-
tion. Arch. Surg. 
This is a detailed account of the 23 patients in 
series III and an effort to explain the excessive rror-
tality in this late Denver experience. A nurrber of 
these recipients had thoracic duct drainage ('IDD) es-
tablished on the same day as their transplant. 
